Orthopedics Articles
Orthopedics
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Orthopedics
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Orthopedics
        Arthritis/Rheumatology
        Arthroscopy
        Basic Science/Genetics
        Bone Metabolism
        Clinical Pharmacology
        Economics of Medicine
        Foot and Ankle
        Hand and Wrist
        Hip
        Knee
        New Products
        Oncology
        Pain Management
        Pediatric Ortho/Rheum
        Popular Press
        Radiology/Diagnostics
        Shoulder and Elbow
        Spine
        Sports Medicine
        Surgical Technique
        Trauma
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
MDLinx Email Article

To email this article, enter your own "From Email" address,
the recipient's "To Email" address, and click the "Send Email" button.
You may send to up to 5 email addresses.
*From Email:  
*To Email:  
To Email:  
To Email:  
To Email:  
To Email:  
High-grade osteosarcoma of the extremities metastatic to the lung: Long-term results in 323 patients treated combining surgery and chemotherapy, 1985–2005
Briccoli A et al. - In a study of high-grade osteosarcoma of the extremities metastatic to the lung, it was concluded that in pts with recurrent resectable pulmonary metastases from high-grade osteosarcoma treated with adjuvant or neoadjuvant chemotherapy, thoracotomy should always be considered regardless of the number of previous lung relapses and the number of secondary pulmonary lesions.

Methods
  • 323 pts, 88 with resectable lung metastases at diagnosis and 235 with localized disease at presentation who relapsed with lung metastases, were treated.

Results
  • 498 lung surgeries and 607 thoracotomies were performed.
  • 5-yr overall survival was 37%.
  • Final outcome was significantly related to presence or absence of metastasis, time of first relapse and presence of local recurrences.
  • According to stage of disease, the rate of a 5-yr event-free survival (EFS) was 36% for pts with localized disease who later relapsed and 9% for pts with resectable lung metastases at presentation.
  • There were no differences in EFS between pts who underwent 2 or 3 thoracotomies and pts who had 4 or 5 thoracotomies (7.5 vs 18.7%).
[more...]
Sponsor

Read a Different Specialty

General Orthopedics
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

General Orthopedics Profession Index

General Orthopedics
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.